EPCLUSA 150 MG/37,5 MG GRANULADO RECUBIERTO EN SOBRE

Gilead Sciences Ireland Unlimited Company🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: ef617002ae9df034
Drug Cima Aemps Name: EPCLUSA 150 MG/37,5 MG GRANULADO RECUBIERTO EN SOBRE
Register Number: 1161116003
Holder Company Name: Gilead Sciences Ireland Unlimited Company
Marketing Company Name: Gilead Sciences S.L.
Holder Company Detail Path: /organization/gilead-sciences-ireland-unlimited-company
Authorization Date: 2023-07-27
Dosage Form: GRANULADO RECUBIERTO
Dose: 150 MG/ 37,5 MG
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Gilead Sciences Ireland Unlimited Company
Company Detail Path: /organization/gilead-sciences-ireland-unlimited-company

SOFOSBUVIR

150 mg

VELPATASVIR

37,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 27, 2023

Approval ID

ef617002ae9df034

Type

Standard